Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-coinfected Patients
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Angel Garcia, MD
Hospital Universitario de Valme. Sevilla. Spain
Principal Investigator - Antonio Rivero, MD, PhD
Hospital Universitario Reina Sofía. Córdoba. Spain
Principal Investigator - Luis F Lopez-Cortes, MD, PhD
Infectious Disease Service. Hospitales Universitarios Virgen del Rocio. Sevilla. Spain
Study Director - Mercedes Gonzalez, MD, PhD
Hospital Universitario Virgen de la Victoria. Malaga. Spain
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Infectious Diseases Service.Hospitales Universitarios Virgen del Rocio
Seville, Sevilla, Spain
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2007
- Primary completion
- 31 May 2010
- Completion
- 31 May 2010
- Last update posted
- 18 May 2010
- Registered enrollment
- 71
- Registry id
- NCT00553930
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.